𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Making the leap from cost analysis to cost-effectiveness

✍ Scribed by Mark Pennington; Chris Vernazza; Peter Heasman

Book ID
109361051
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
97 KB
Volume
36
Category
Article
ISSN
0303-6979

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Affordability and cost-effectiveness: de
Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane
✍ P. Pedram Sendi; Andrew H. Briggs 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Much recent research interest has focused on handling uncertainty in cost‐effectiveness analysis and in particular the calculation of confidence intervals for incremental cost‐effectiveness ratios (ICERs). Problems of interpretation when ICERs are negative have led to two important and

Bayesian cost-effectiveness analysis wit
Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane
✍ Miguel A. Negrín; Francisco J. Vázquez-Polo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d

An opportunity cost approach to sample s
An opportunity cost approach to sample size calculation in cost-effectiveness analysis
✍ A. Gafni; S. D. Walter; S. Birch; P. Sendi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract The inclusion of economic evaluations as part of clinical trials has led to concerns about the adequacy of trial sample size to support such analysis. The analytical tool of cost‐effectiveness analysis is the incremental cost‐effectiveness ratio (ICER), which is compared with a threshol